Fluidigm Corporation (NASDAQ:LAB), a company specializing in microfluidic systems for the life sciences industry with a market capitalization of $458 million, has seen its stock price touch a 52-week ...
A device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.
University of Oulu's Next-Generation Molecular Sensors project focuses on developing ultrasensitive biosensors, enhancing ...
The following highlights showcase the most pivotal, innovative research published across multiple therapeutic areas in ...
Bonus Sep 23, 2015 Sep 26, 2015 Aug 08, 2015 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jul 30, 2009 Aug 01, 2009 Jun 06, 2009 Bonus Ratio: 1 share(s) for every 1 shares held Divi's ...